/NVCR

Novocure Ltd

NVCR

$15.51USD↑+1.04%+0.16 today

MARKET CAP

1.8B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$15 – $16

52W RANGE

$10

$21

AI Summary

Stalk

TrimMedium

NVCR has broken key support in a Stage 4 environment, signaling accelerating downside. Medium-term bearish asymmetry is reinforced by support failure and lower highs/lows. Short-term, price is extended below declining EMAs and in oversold territory, suggesting risk of a countertrend bounce. Therefore, focus on trimming positions on rallies into resistance.

↑Q2 net revenue $184M (+16% YoY) driven by expanding patient base
↑Optune Pax launch for pancreatic cancer shows 74% disease control rate
↓Net loss $16M in Q2 and $136M YTD pressures cash flow

Full analysis →

Buying

9

institutions

Selling

4

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	13.41 M	203.22 M	+219.93 K	+41.3%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUY	1.95 M	29.57 M	+400.36 K	+74.9%	0.04%
JC Jpmorgan Chase & Co Q2 2026	BUY	1.67 M	25.94 M	+740.92 K	+169.2%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	1.10 M	16.65 M	+827.20 K	+475.8%	0.01%
PA Point72 Asset Management, L.P. Q2 2026	SELL	803.12 K	12.17 M	+-558.27 K	-18.0%	0.01%
BA Balyasny Asset Management L.P. Q2 2026	BUY	480.00 K	7.27 M	+468.17 K	+5539.0%	0.01%
CA Citadel Advisors LLC Q2 2026	BUY	373.74 K	5.66 M	+175.50 K	+162.0%	0.00%
MM Millennium Management LLC Q2 2026	BUY	278.07 K	4.21 M	+186.85 K	+323.7%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	90.00 K	981.45 K	+45.00 K	+68.7%	0.00%
MG Man Group Plc Q2 2026	BUYNEW	52.72 K	798.68 K	+52.72 K	+0.0%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	200.00	3.03 K	+-30.81 K	-99.1%	0.00%
TR T. Rowe Price Investment Management, Inc. Q2 2026	SELL	0.00	0.00	+-927.38 K	-100.0%	0.00%
EP Eversept Partners, LP Q2 2026	SELL	0.00	0.00	+-134.92 K	-100.0%	0.00%